Ergotamine derivatives
Balcells, M.
Revista de Neurologia 23(Suppl 2): S162-S165
1995
ISSN/ISBN: 0210-0010 PMID: 7497281 Document Number: 450936
Document emailed within 1 workday
Related Documents
Retterstol, N. 1973: Ergotamine addiction in migraine patients Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(28): 2122Schild, H.O. 1976: Some aspects of receptor pharmacology of ergotamine Postgraduate Medical Journal 52suppl 1: 9-11
Gallo, César.; de la Fuente, Bén.; García-Alcalde, M.Luisa.; Antuña, A. 2002: Ergotism in a patient treated with ritonavir and ergotamine Medicina Clinica 119(14): 558-559
Wall, M.C. 1972: Ergotamine tartrate in migraine and the dangers of overdose Nursing Times 68(50): 1585
Moltó Ripoll, F.; Merenciano Cortina, F.J.; Herraiz Romero, I.; Vilas Ferrol, I.; Fernández-Moscoso López-Duran, A.; Muñoz Nuñez, C.; Martínez Salinas, P. 1995: Retroperitoneal fibrosis due to ergotamine. Apropos a case Archivos Espanoles de Urologia 48(4): 400-403
Felix, R.H.; Carroll, J.D. 1970: Upper limb ischaemia due to ergotamine tartrate Practitioner 205(225): 71-72
Tüttenberg, K.H.; Schuster, C.J.; Ungern-Sternberg, A.V.; Kottmann, U.R.; Schniepp, K.E.; Limbourg, P. 1976: Peripheral circulatory disorder in the treatment of migraine with ergotamine Die Medizinische Welt 27(29): 1398-1400
Halim, A.F. 1981: Simultaneous spectrophotometric determination of caffeine and ergotamine in tablets Die Pharmazie 36(2): 157-158
Sofia, R.D.; Vassar, H.B. 1975: The effect of ergotamine and methysergide on serotonin metabolism in the rat brain Archives Internationales de Pharmacodynamie et de Therapie 216(1): 40-50
Murad, M.H.; Miller, F.A.; Glockner, J. 2011: Multi-system fibrosis and long-term use of ergotamine Annals of the Academy of Medicine Singapore 40(7): 327-328
Bonuso, S.; Di Stasio, E.; Marano, E.; Covelli, V.; Testa, N.; Tetto, A.; Buscaino, G.A. 1994: The antimigraine effect of ergotamine: a role for alpha-adrenergic blockade? Acta Neurologica 16(1-2): 1-10
Goldman, J.M.; Hadley, M.E. 1970: Direct agonistic and antagonistic effects of ergotamine on vertebrate melanophores Archives Internationales de Pharmacodynamie et de Therapie 183(2): 239-246
Regazzi, M.B.; Rondanelli, R.; Calvi, M.; Brè, E.; Restelli, E. 1985: In vivo disposibility of caffeine and ergotamine tartrate after rectal administration Il Farmaco; Edizione Pratica 40(8): 259-265
Packard, R.C. 1977: Case report: changes in migraine headache pattern following sudden increase in ergotamine intake Postgraduate Medicine 61(5): 255 257
Stürmer, E. 1976: Effects of ergotamine and dihydroergotamine on the resistance and capacitance vessels of skin and skeletal muscle in the cat Postgraduate Medical Journal 52suppl. 1: 32-39
Tadzhiev, M.A.; Ikramov, L.T. 1992: The use of the orthogonal function method for calculating the background in determining ergotamine in biological material Sudebno-Meditsinskaia Ekspertiza 35(2): 30-32
Yuill, G.M.; Swinburn, W.R.; Liversedge, L.A. 1972: A double-blind crossover trial of isometheptene mucate compound and ergotamine in migraine British Journal of Clinical Practice 26(2): 76-79
Mouillé, P. 1970: Interactions between various alpha and beta adrenergic inhibitors and ergotamine during inversion of the pressure effects of isoprenaline in the dog Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(5): 1003-1006
Hendrikx, M.; Van Dorpe, J.; Flameng, W.; Daenen, W. 1996: Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature Journal of Heart Valve Disease 5(2): 235-237
Lukasiak, J.; Radecki, A.; Jamrógiewicz, Z. 1977: Silicone derivatives of medicinal agents. XI. Methylsilyl derivatives of methyl and propyl p-hydroxybenzoate Acta Poloniae Pharmaceutica 34(6): 615-620